Fig. 3From: MHC-I genotype and tumor mutational burden predict response to immunotherapyKaplan-Meier curves showing the effects of a TMB on overall survival, b TMB on progression-free survival, and c minimum PHBR score on overall survival and d minimum PHBR score on progression-free survival in the combined melanoma cohortBack to article page